Clinical Trials Logo

Filter by:
NCT ID: NCT02844920 Completed - Uterine Fibroids Clinical Trials

Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids

OPEN
Start date: July 20, 2017
Phase:
Study type: Observational

This study is designed to observe the presence or absence of intrauterine adhesions at 6 weeks after treatment with the Sonata® System through hysteroscopic evaluation by third party readers.

NCT ID: NCT02844049 Recruiting - Clinical trials for Obsessive-Compulsive Disorder

European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS

EQOLOC
Start date: September 2016
Phase: N/A
Study type: Interventional

Obsessive-Compulsive Disorder (OCD) is among the most disabling psychiatric disorders as more than 40% of patients are resistant to the standard pharmacological and psychotherapy approaches and about 10% show severe disability and require institutionalization. These resistant patients may benefit from new surgical therapeutic approaches such as Deep Brain Stimulation (DBS) using high frequency stimulation of specific cerebral regions to modulate neural networks. Although promising, these results need nevertheless to be replicated and confirmed within a larger cohort of patients and considering a different main objective, instead of clinical improvement only. Indeed, despite a positive treatment response, adaptive functioning and quality of life may continue to be negatively impacted in OCD. Thus beyond symptom reduction, health-related quality of life (QoL) represents a more important objective of a treatment, as it includes both the individual's functional status and the individual's subjective perception of the impact of the illness on the patient's life. STN DBS induces significant clinical improvement, which may not be proportional to the QoL gain. Consequently, QoL appears to be a better outcome to target in the coming studies than clinical improvement alone. THe investigators thus propose a prospective study assessing the QoL changes of resistant OCD patients under STN DBS+BMT versus Best Medical Treatment (BMT) at 12 months, in order to assess the DBS induced gain in QoL in BMT-managed patients versus BMT alone.

NCT ID: NCT02843386 Completed - Uveal Melanoma Clinical Trials

Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma

FOTEADJ
Start date: June 23, 2009
Phase: Phase 3
Study type: Interventional

After the local treatment of the primary tumor (protonbeam-therapy, enucleation, external radiotherapy) patients with high risk of metastasis are randomized between: - Adjuvant chemotherapy with Fotemustin. - Observation Both groups are followed during 3 years for Metastasis- Free Survival, safety and tolerance of Fotemustin, quality of life, and Overall Survival.

NCT ID: NCT02841306 Completed - Clinical trials for Rhegmatogenous Retinal Detachment

Ursodeoxycholic Acid for Rhegmatogenous Retinal Detachment

UDCA-RD
Start date: July 2016
Phase: Phase 1
Study type: Interventional

26 patients presenting a rhegmatogenous retinal detachment with more than 4 days of duration will be prospectively included. A single dose of ursodeoxycholic acid will be administered orally before surgery at different time-points in 22 subjects. Standard surgery will be performed and ocular samples will be collected during the procedure. Ursodeoxycholic acid treatment will be continued in treated patients during 3 months after surgery. Ocular and serum samples from the 4 untreated patients will serve as negative controls for the determination of UDCA levels.

NCT ID: NCT02840513 Terminated - HIV Clinical Trials

Smartphone App and CO Self-monitoring for Smoking Cessation

SMART-CO
Start date: June 1, 2017
Phase: Phase 4
Study type: Interventional

This randomized controlled trial is going to evaluate whether an intervention consisting of a smartphone application to assist smokers living with HIV to quit in combination with CO self-monitoring compared to stop smoking counselling by physicians during usual care results in higher self-reported and biochemically verified smoking cessation rates at 6 months. .

NCT ID: NCT02840396 Completed - Language Clinical Trials

Effect of rTMS of the Dorsolateral Prefrontal Cortex on Language Production in Healthy Participants

Start date: March 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex (DLPFC) on language production.

NCT ID: NCT02840370 Completed - Aphasia Clinical Trials

Effect of Stimulation of the Prefrontal Cortex on Language Production in Aphasic Patients

Start date: May 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether transcranial direct current stimulation (tDCS) of the prefrontal cortex (PFC) influences lexical access and language production. The experimental paradigm will assess the impact of prefrontal stimulation by tDCS versus sham tDCS (S-tDCS) over the PFC of patients with chronic post-stroke aphasia during three language production tasks and a nonverbal executive functions task.

NCT ID: NCT02840188 Completed - Radius Fractures Clinical Trials

Young Goalkeeper's Fracture: Radiographic Findings

Goalkeeper
Start date: July 2016
Phase: N/A
Study type: Observational

The aim of this project is to evaluate retrospectively goalkeeper's fractures in children using the children fracture classification and to evaluate the distal radius tilt angle of the growth plate on plain radiographs of the forearm. Patients positive for goalkeeper's fracture will prospectively answer a questionnaire concerning risk factors and circumstances during the injury.

NCT ID: NCT02839018 Completed - Muscle Weakness Clinical Trials

Nutrient Pattern Analysis in Critically Ill Patients (NAChO)

NAChO
Start date: January 2017
Phase:
Study type: Observational

Little is known about nutritional Parameters that potentially influence the course of intensive-care unit acquired weakness (ICU - AW). The investigators aim to elucidate the nutritional profiles in blood, urine and muscle in respective patients at risk.

NCT ID: NCT02837705 Completed - Prion Diseases Clinical Trials

Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers

PRNP
Start date: September 1, 2015
Phase:
Study type: Observational [Patient Registry]

The human Prion diseases can be classified into sporadic, acquired and inherited forms. Inherited forms usually manifest in higher age so there have to be factors preventing Prion propagation in young mutation carriers. Antibodies against the flexible tail of Prions have been shown to be protective in mice. The investigators intend to screen mutation carriers and controls for the presence of Prion autoantibodies.